2012 | Aarkstore.com | Han all biopharma co., ltd. – product pipeline review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “HanAll Biopharma Co., Ltd. -
Product Pipeline Review - 2012” provides data on the HanAll Biopharma Co., Ltd.’s
research and development focus. The report includes information on current
developmental pipeline, complete with latest updates, and features on discontinued
and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, HanAll Biopharma Co., Ltd.’s corporate website, SEC filings,
investor presentations and featured press releases, both from HanAll Biopharma
Co., Ltd. and industry-specific third party sources, put together by Global Markets
Direct’s team.
Scope
- HanAll Biopharma Co., Ltd. - Brief HanAll Biopharma Co., Ltd. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of HanAll Biopharma Co., Ltd. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
Reasons to buy

2. - Evaluate HanAll Biopharma Co., Ltd.’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of HanAll Biopharma Co., Ltd. in its therapy areas of
focus.
Table of contents:
List of Tables 6
List of Figures 6
HanAll Biopharma Co., Ltd. Snapshot 7
HanAll Biopharma Co., Ltd. Overview 7
Key Information 7
Key Facts 7
HanAll Biopharma Co., Ltd. – Research and Development Overview 8
Key Therapeutic Areas 8
HanAll Biopharma Co., Ltd. – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Pipeline Products – Combination Treatment Modalities 13
HanAll Biopharma Co., Ltd. – Pipeline Products Glance 14
HanAll Biopharma Co., Ltd. – Late Stage Pipeline 14
Registration Filed Products/Combination Treatment Modalities 14
Phase III Products/Combination Treatment Modalities 15
HanAll Biopharma Co., Ltd. Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
HanAll Biopharma Co., Ltd. – Early Stage Pipeline Products 19
Pre-Clinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
HanAll Biopharma Co., Ltd. – Drug Profiles 21
ARBs + Ca-Antagonists 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
ARBs + Statins 22

3. Product Description 22
Mechanism of Action 22
R&D Progress 22
Hanferon 23
Product Description 23
Mechanism of Action 23
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
IntelGenx Corp. – Product Pipeline Review – 2012
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012
JADO Technologies GmbH – Product Pipeline Review – 2012

4. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012
NeuroSearch A/S – Product Pipeline Review – 2012
NovaDel Pharma, Inc. – Product Pipeline Review – 2012
Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com